Form 8-K - Current report:
SEC Accession No. 0001437749-21-009711
Filing Date
2021-04-23
Accepted
2021-04-23 16:00:51
Documents
14
Period of Report
2021-04-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20210422_8k.htm   iXBRL 8-K 34884
2 EXHIBIT 99.1 ex_243250.htm EX-99.1 9769
  Complete submission text file 0001437749-21-009711.txt   187061

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20210421.xsd EX-101.SCH 3700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20210421_def.xml EX-101.DEF 11975
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20210421_lab.xml EX-101.LAB 16020
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20210421_pre.xml EX-101.PRE 12184
7 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20210422_8k_htm.xml XML 2683
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 21849661
SIC: 2836 Biological Products, (No Diagnostic Substances)